Conatus Pharmaceuticals (CNAT US)

Conatus Pharmaceuticals, Inc. develops therapeutics to treat liver disease. The Company offers drugs to control programmed cell death that contributes to a range of liver diseases and cancer treatments. Conatus Pharmaceuticals provides its products in the United States.